Evaluation of a point-of-care glucose meter for general use in complex tertiary care facilities

Clinical Biochemistry

Volumn 42, Issue 10-11, 2009, Pages 1104-1112

  Chan, Pak Cheung R ^a,b   Rozmanc, Mary ^a   Seiden Long, Isolde ^b,c   Kwan, Jason ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DYNACARE LABORATORIES   (Canada)

Author keywords

Glucose meter; Glycemic control; Method evaluation; Tertiary care

Indexed keywords

3 HYDROXYBUTYRIC ACID; ASCORBIC ACID; BILIRUBIN; GALACTOSE; GLUCOSE; HEMOGLOBIN; LACTIC ACID; MALTOSE; PARACETAMOL; URIC ACID;

ACCURACY; ARTICLE; BLOOD ANALYSIS; BLOOD GLUCOSE METER; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEALTH CARE FACILITY; HEMATOCRIT; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; NURSING STAFF; POINT OF CARE TESTING; PRIORITY JOURNAL; SCORING SYSTEM; TERTIARY HEALTH CARE;

BLOOD GLUCOSE; HEALTH FACILITIES; HUMANS; POINT-OF-CARE SYSTEMS; REAGENT STRIPS; REPRODUCIBILITY OF RESULTS;

EID: 67349087386     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.03.023     Document Type: Article

References (52)

1. Greyson J. Quality control in patient self-monitoring of blood glucose. Diabetes Care 16 (1993) 1306-1308
2. Improving glucose monitoring for diabetics. FDA Consumer. 1990;May:32-35.
3. Gaines AR, Pierce LR, Bernhardt PA. Fatal iatrogenic hypoglycemia: falsely elevated blood glucose readings with a point-of-care meter due to a maltose-containing intravenous immune globulin product. CBER article: 2008. Available at: http://www.fda.gov/cber/safety/glucfalse.htm. Accessed Oct 18, 2008.
4. ISMP Medication Safety Alert 2008; vol 13 issue 2.
5. American Diabetes Association. Clinical practice recommendations 2000: implications of the Diabetes Control and Complications Trial. Diabetes Care 23 Suppl. 1 (2000) S24-S26
6. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 23 Suppl. 1 (2000) S80-S82
7. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 27 Suppl. 2 (2003) s21-s23
8. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 27 Suppl 2 (2003) s113-s116
9. Mesotten D., and Van den Berghe G. Clinical potential of insulin therapy in critically ill patients. Drugs. 63 (2003) 625-636
10. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345 (2001) 1359-1367
11. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354 (2006) 449-461
12. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann. Thorac. Surg. 67 (1999) 352-360
13. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J. Thoracic. Cardiovasc. Surg. 125 (2003) 1007-1019
14. Langley J., and Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab. Res. Rev. 23 (2007) 184-192
15. Atkin S.H., Dasmahapatra A., Jaker M.A., Chorost M.I., and Reddy S. Fingerstick glucose determination in shock. Ann. Intern. Med. 114 (1991) 1020-1024
16. Jocobs E., Vadasdi E., Roman S., and Coman N. The influence of hematocrit, uremia and hemodialysis on whole blood glucose analysis. Lab. Med. 24 (1993) 295-300
17. Tang Z., Louie R.F., Lee J.H., Lee D.M., Miller E.E., and Kost G.J. Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing. Crit. Care Med. 29 (2001) 1062-1070
18. Kilpatrick E.S., Rumley A.G., and Smith E.A. Variations in sample pH and pCO2 affect ExacTech meter glucose measurements. Diabet. Med. 11 (1994) 506-509
19. Kilpatrick E.S., Rumley A.G., and Rumley C.N. The effect of heamolysis on blood glucose meter measurement. Diabet. Med. 12 (1995) 341-343
20. Lewis K., Joyce-Nagata B., and Fite E.G. The effect of time and temperature on blood glucose measurements. Home. Healthcare. Nurs. 10 (1992) 56-61
21. Wens R., Taminne M., Devriendt J., Collart F., Broeders N., Mestrez F., Germanos H., and Dratwa M. A previously undescribed side effect of Icodextrin. Overestimation of glycemia by glucose analyzer. Perit. Dial. Int. 18 (1988) 603-609
22. Disse E., and Thivolet C. Hypoglycemic coma in a diabetic patient on peritoneal dialysis due to interference of icodextrin metabolites with capillary blood glucose measurements. Diabetes Care 27 (2004) 2279
23. Pavlicek V., Garzoni D., Urech P., and Brandle M. Inaccurate self monitoring of blood glucose readings in patients on chronic ambulatory peritoneal dialysis with icodextrin. Exp. Clin. Endocrinol. Diabetes. 114 (2006) 124-166
24. FDA. Important Safety Information on interference with blood glucose measurement following use of parenteral maltose/parenteral galactose/oral xylose-containing products. 9 November 2005; Available at: www.fda.gov/cber/safety/maltose110405.htm. Accessed Sept 13, 2008.
25. Cartier L.J., Leclerc P., Pouliot M., Nadeau L., Turcotte G., and Fruteau-de-Laclos B. Toxic levels of acetaminophen produce a major positive interference on glucometer Elite and Accu-chek advantage glucose meters. Clin. Chem. 44 (1998) 893-894
26. Duncan K., Braithwaite S.S., Chapman J., and Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 30 (2007) 403-409
27. King J.M., Eigenmann C.A., and Colagiuri S. Effect of ambient temperature and humidity on performance of blood glucose meters. Diabet. Med. 12 (1995) 337-340
28. Ridgewell P., and Holmes J. Effect of temperature on results obtained with the Reflolux II. Clin. Chem. 36 (1990) 1705-1706
29. Gregory M., Ryan R., Barnett J.C., and Youtz T. Altitude and relative humidity influence results produced by glucose meters using dry reagent strips. Clin. Chem. 34 (1988) 1312
30. Gautier J.F., Bigard A.X., Douce P., Duvallet A., and Cathelineau G. Influence of simulated altitude on the performance of five blood glucose meters. Diabet. Care. 19 (1996) 1430-1433
31. Hilton S., Rink E., Fletcher J., Sibbald B., Freeling P., Szczepure A., Davies C., and Stilwell J. Near patient testing in general practice: attitudes of general practitioners and practice nurses, and quality assurance procedures carried out. Brit. J. Gen. Pract. 44 (1994) 577-580
32. Nanji A.A., Poon R., and Hinberg I. Near-patient testing: quality of laboratory test results obtained by non-technical personnel in a decentralized setting. Am. J. Clin. Pathol. 89 (1988) 797-801
33. Gray T.A., Freedman D.B., Burnett D., Szczepura A., and Price C.P. Evidence based practice: clinician's use and attitudes to near patient testing in hospitals. J. Clin. pathol. 49 (1996) 903-908
34. Cohen F.E., Sater B., and Feingold K.R. Potential danger of extending SMBG techniques to hospital wards. Diabet. Care. 9 (1986) 320-322
35. Boyd J.C., and Bruns D.E. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin. Chem. 47 (2001) 209-214
36. Clinical Laboratory Improvement Amendments of 1988 (CLIA '88). Final Rule. Department of Health and Human Services. Federal. Register. 57 (1992) 7002-7288
37. Parkes J.L., Pardo S., Slatin S.L., and Ginsberg B.H. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 23 (2000) 1143-1148
38. NCCLS. Point-of-care blood glucose testing in acute and chronic care facilities; Approved Guideline - Second Edition. C30-A2 Vol. 22 No. 17.
39. ISO 15197 In vitro diagnostic test systems - requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. First edition dated 2003-05-01. ISO 15197:2003(E) International Standards Organization, Geneva, Switzerland. Available at: www.iso.org. Accessed Oct 18, 2008.
40. Kost G.J., Tran N.K., Abad V.J., and Louie R.F. Evaluation of point-of-care testing accuracy using locally-smoothed median absolute difference curves. Clin. Chim. Acta 389 (2008) 31-39
41. Harris E.K., and Yasaka T. On the calculation of a "reference change" for comparing two consecutive measurements. Clin. Chem. 29 (1983) 25-30
42. Iglesias-Canadell N., Petersen P.H., Jensen E., Ricos C., and Jorgensen P.E. Reference change values and power functions. Clin. Chem. Lab. Med. 42 (2004) 415-422
43. Davidson P.C., Steed R.D., and Bode B.W. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 28 10 (2005) 2418-2423
44. Holtzinger C., Szelag E., DuBois J.A., Shirey T.L., and Presti S. Evaluation of a new POCT bedside glucose meter and strip with hematocrit and interference corrections. Point Care 7 (2008) 1-6
45. Khan A.I., Vasquez Y., Gray J., Wians F.H., and Kroll M.H. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch. Pathol. Lab. Med. 130 (2006) 1527-1532
46. Lippi G., Salvagno G.L., Guidi G.C., Negri M., and Rizzotti P. Evaluation of four self-monitoring blood glucose meters. Clin. Chim. Acta 43 (2006) 408-413
47. Fraser C.G., Petersen P.H., Liber J.C., and Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann. Clin. Biochem. 34 (1997) 8-12
48. Mooy J.M., Grootenhuis P.A., de Vries H., Kostense P.J., Popp-Snijders C., Bouter L.M., and Heine R.J. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39 (1996) 298-305
49. Tang Z., Lee J.H., Louie R.F., and Kost G.J. Effects of different hematocrit levels on glucose measurements with handheld meters for point of care testing. Arch. Pathol. Lab. Med. 124 (2000) 1135-1140
50. Kilpatrick E.S., Rumley A.G., and Myin H. The effect of variations in Hematocrit, mead cell volume and red cell count on reagent strip tests for glucose. Ann. Clin. Biochem. 30 (1993) 485-487
51. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 19 Suppl 1 (1996) S62-66
52. Karon B.S., Griesmann L., Scott R., Bryant S.C., Dubois J.A., Shirey T.L., Presti S., and Santrach P.J. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol. Ther. 10 (2008) 111-120